Vifor Pharma AG (VIFN:SW) (GNHAY) PT Raised to CHF127 at UBS

March 29, 2021 5:24 AM EDT
Get Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 22 | Down: 13 | New: 31
Trade Now! 
Join SI Premium – FREE
UBS analyst Laura Sutcliffe raised the price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF127.00 (from CHF119.00) while maintaining a Neutral rating.

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Intl Ratings